# A Single-Center, Prospective Phase II Clinical Study of Proton Beam Intensity-Modulated Stereotactic Radiotherapy for Early-Stage Non-Small Cell Lung Cancer

> **NCT07412327** · NA · NOT_YET_RECRUITING · sponsor: **Guangzhou Concord Cancer Center** · enrollment: 65 (estimated)

## Conditions studied

- Early-Stage Lung Cancer
- Lung Cancer

## Interventions

- **RADIATION:** Stereotactic Body Proton Therapy

## Key facts

- **NCT ID:** NCT07412327
- **Lead sponsor:** Guangzhou Concord Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-02-20
- **Primary completion:** 2029-07-01
- **Final completion:** 2029-07-01
- **Target enrollment:** 65 (ESTIMATED)
- **Last updated:** 2026-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07412327

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07412327, "A Single-Center, Prospective Phase II Clinical Study of Proton Beam Intensity-Modulated Stereotactic Radiotherapy for Early-Stage Non-Small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07412327. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*